1933 - 2033

Odette Cancer Centre – A Multi-Center, Open-Label, Single-Arm Phase II Trial of Bendamustine, Rituximab and the Second Generation BTK Inhibitor Acalabrutinib in Previously Untreated Waldenstrom’s Macroglobulinemia (BRAWM)

It seems we can’t find what you’re looking for. Perhaps searching can help.